TrialClinical pharmacology and therapeutics2021

Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein-Mediated Drug-Drug Interactions in Healthy Volunteers.

Takeshi Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.